SightLine Partners
Overview
SightLine Partners is an alternative investment manager focused on secondary buyouts and joint venture transactions for portfolios of high-quality medical technology, digital health, life sciences and healthcare service companies . The firm seeks to invest in healthcare, life science, manufacturing, oncology, digital health & SaaS sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Endoluminal Solutions Inc. | May 2019 | Series I | Co-investor |
| Monteris Medical | Jun 2017 | Series C | Lead |
| Earlens Corporation | Oct 2018 | Series D | - |
| Magnolia Medical Technologies | Feb 2022 | Growth Equity | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SightLine Partners based?
SightLine Partners is headquartered in Bloomington, Minnesota, United States.
When was SightLine Partners founded?
SightLine Partners was founded in 2004.
How many portfolio companies does SightLine Partners have?
SightLine Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in SightLine Partners's portfolio?
Portfolio companies visible on Caplight include Endoluminal Solutions Inc., Monteris Medical, Earlens Corporation, Magnolia Medical Technologies.
What was SightLine Partners's most recent investment shown here?
SightLine Partners's most recent investment in this portfolio sample was in Magnolia Medical Technologies in 2022.
What sectors does SightLine Partners focus on?
SightLine Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does SightLine Partners focus on?
SightLine Partners typically invests at the Late stage.
What is SightLine Partners's AUM?
SightLine Partners's assets under management are estimated between $250.0M and $500.0M.